Gossamer Bio Inc. (GOSS) Tops Q1 EPS by 1c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.52), $0.01 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• UBS Reiterates Neutral Rating on Wingstop (WING), Expects Q2 to Reflect Pressured Sales Trends
• IBM plunges 19% as memory capex squeeze derails Q2 earnings